This group utilized the same assay to detect urinary podocalyxin in diabetic patients with glomerulopathy and found that there was a significant difference in control, healthy subjects and normoalbuminuric, diabetic patients [67]. The gene discussed is PODXL; the disease is lipoprotein glomerulopathy.